News Detail

Maryland, 5 March 2025: The US Food and Drug Administration (FDA) recently issued two warning letters to companies in India and the US for various violations of good manufacturing practices (GMPs) related to the production of drug products. In both cases, investigators identified......
View Details
Source : Regulatory Focus
US Food and Drug Administration (FDA)
Granules India Limited
Gagillapur Village
good manufacturing practices (GMPs)
Related News
- Joint team of police, drugs department and anti-narcotics task force raided warehouse, recovered huge quantity of Tramadol Pills (22-03-2025)
- Karnataka notifies NDPS Rules, Essential Narcotic Drugs to be regulated under Central Rules (22-03-2025)
- One hundred teams participated in 'Operation Garuda', uncovering nearly 40 different types of drugs being sold without prescriptions (22-03-2025)
- List of OTC drugs to be Submitted to Govt Soon: Panel Chief (21-03-2025)
- DCA seized four medicines for misleading 'Leucoderma', 'Tuberculosis' and 'Fever' treatment claims (21-03-2025)
- Skin specialists flag widespread quackery in Kerala (21-03-2025)
- SHRC orders criminal proceedings against fake doctor (21-03-2025)
- Gujarat HC stays GST action against Gujarat Medical Council, other boards (21-03-2025)
- CEPI and AstraZeneca to advance discovery into novel antibody (21-03-2025)
- FIR against 3 animal husbandry dept officials booked for sending damaged vaccine to Hospitals (21-03-2025)